Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2026-01-11 @ 12:18 PM
Study NCT ID:
NCT04032704
Status:
TERMINATED
Last Update Posted:
2025-03-10
First Post:
2019-07-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
Sponsor:
Seagen Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-28
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-23
First Submit QC Date:
None
Study First Post Date:
2019-07-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-21
Results First Submit QC Date:
None
Results First Post Date:
2025-03-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-25
Last Update Post Date:
2025-03-10
Last Update Post Date Type:
ACTUAL